Trial Profile
Time-lapse Assessed Evaluation of Embryo Development After Stimulation With Either Recombinant Follicle Stimulating Hormone (FSH) or Urine-derived Follicle Stimulating Hormone (FSH).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Menotropin (Primary) ; Recombinant follicle-stimulating hormone (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 13 Sep 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 May 2011 New trial record